Literature DB >> 7248150

Measurement of Gross cell-surface antigen and p30 level in murine retrovirus-infected cell lines.

D Gerlier, S Gisselbrecht, B Guillemain, J F Doré.   

Abstract

The level of Gross cell-surface antigen (GCSAa) expression at the surface of murine retrovirus-infected fibroblasts was determined by quantitative absorption of the anti-GCSAa activity of a serum produced in syngeneic W/Fu rats immunized against (C58NT)D lymphoma, and tested in a cytotoxicity assay against E male G2 lymphoma cells. While GCSAa was specifically expressed on Gross-type virus (G-MuLV)-induced lymphoma cells, and while G-MuLV and G-related MuLV induced a high level of GCSAa expression on murine fibroblasts, the Friend-Moloney-Rauscher (FMR) group viruses (FMR MuLV) and xenotropic isolates were also able to induce a high or intermediate level of GCSAa. Since GCSAa has been shown to be borne by glycosylated precursors of the viral nucleocapside (gp95gag and gp85gag), the amount of GCSAa expressed on these cells was compared to the level of cytoplasmic p30. In G- and G-related MuLV-infected cell lines, a significant relationship was found between the amount of GCSAa and the level of p30, whereas in FMR-MuLV or xenotropic virus-infected cells the amount of GCSAa varied independently of the p30 level. These results could explain the discrepancy in the specificity of expression of GCSAa in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7248150      PMCID: PMC2010674          DOI: 10.1038/bjc.1981.97

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  43 in total

1.  Productive infection and morphologic alteration of human cells by a modified sarcoma virus.

Authors:  P J Fischinger; T E O'Connor
Journal:  J Natl Cancer Inst       Date:  1970-02       Impact factor: 13.506

2.  Study of the antigenic specificity of Graffi leukemic cells.

Authors:  J P Levy; J C Leclerc; B Varet; E Oppenheim
Journal:  J Natl Cancer Inst       Date:  1968-09       Impact factor: 13.506

3.  Production of a potent complement-fixing murine leukemia virus-antiserum from the rabbit and its reactions with various types of tissue culture cells.

Authors:  W Schäfer; E Seifert
Journal:  Virology       Date:  1968-06       Impact factor: 3.616

4.  The G (Gross) leukemia antigen.

Authors:  L J Old; E A Boyse; E Stockert
Journal:  Cancer Res       Date:  1965-07       Impact factor: 12.701

5.  Infection of an established mouse bone marrow cell line (JLS-V9) with Rauscher and Moloney murine leukemia viruses.

Authors:  B S Wright; P A O'Brien; G P Shibley; S A Mayyasi; J C Lasfargues
Journal:  Cancer Res       Date:  1967-09       Impact factor: 12.701

6.  Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems.

Authors:  J L McCoy; A Fefer; J P Glynn
Journal:  Cancer Res       Date:  1967-10       Impact factor: 12.701

7.  Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures.

Authors:  J W Hartley; W P Rowe; R J Huebner
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

8.  Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.

Authors:  J L Jainchill; S A Aaronson; G J Todaro
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

9.  Demonstration of biological activity of a murine leukemia virus of New Zealand black mice.

Authors:  J A Levy; T Pincus
Journal:  Science       Date:  1970-10-16       Impact factor: 47.728

10.  Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses.

Authors:  G Geering; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.